Graph Blockchain see a dramatic increase in demand for protection equipment (PPE)

Graph Blockchain Inc. (CSE: GBLC)  Yesterday,  Andrew Ryu, CEO of Graph Blockchain Inc. announce that the Company…

Sorrento Announces FDA IND Filing Today for COVI-GUARD Neutralizing and High Potency Antibody Against SARS-CoV-2

IND filing today for STI-1499 (COVI-GUARD™) for hospitalized COVID-19 patients. The initial trial is expected to…

ALERT COVID-19 | Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3

RVV | RVVTF TORONTO, July 31, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the…

Datametrex Awarded $208,800 Milestone 3 Completion Payment from Canada’s Defence Innovation Program

TORONTO, July 20, 2020 (GLOBE NEWSWIRE) — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G)…

Datametrex Obtains Rights to Sell COVID-19 Home Test Kits With FDA Registration

TORONTO, June 16, 2020 (GLOBE NEWSWIRE) — Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G,…

Graph Blockchain Provides Update on Launch of BluStem Ecommerce Wellness Platform

Wellness Marketplace platform, BluStem Ltd. (www.BluStem.com) Graph Blockchain Inc. (CSE: GBLC) Toronto, Ontario–(Newsfile Corp. – June 12,…

StageZero Life Sciences Provides an Update on Testing for COVID-19 In the USA.

TORONTO, ON / ACCESSWIRE / May 1, 2020 / StageZero Life Sciences, Ltd (TSX:SZLS) (“StageZero” or the “Company”)…

Graph Blockchain Announces Non-Binding LOI to Procure PPE Products like EN14126 + Type 4 Level C/D Protective Clothing, hand sanitizers, and N95 /KF94 masks

Toronto, Ontario–(Newsfile Corp. – April 23, 2020) –  Graph Blockchain Inc. (CSE: GBLC) (“Graph” or “Company“) is pleased…

Algernon Submits Application to Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial

Algernon Pharmaceuticals Inc. (CSE: AGN) VANCOUVER, British Columbia, April 22, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE:…

WPD Pharmaceuticals and CNS Pharmaceuticals Announce Additional Coronavirus Testing on WP1122 by ImQuest Biosciences

WPD Pharmaceuticals Inc. (CSE: WBIO) VANCOUVER, British Columbia, April 21, 2020 (GLOBE NEWSWIRE) — WPD Pharmaceuticals Inc. (CSE:…

Lexaria Bioscience Files New Patent Utilizing DehydraTECH Technology for Treatment of Infectious Diseases Including COVID-19

Lexaria Bioscience Corp. (OTC:LXRP) (CSE:LXX) (CNSX:LXX.CN) Kelowna, British Columbia – TheNewswire – April 21, 2020 – Lexaria Bioscience Corp. (OTC:LXRP)…

ImmunoPrecise Provides Updates on B Cell Select™ and Deep Display™ Programs for SARS-CoV-2 Antibody Discovery

VICTORIA, April 17, 2020 /CNW/ – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTC QB:…